Chemotherapy after PD‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
暂无分享，去创建一个
D. Rossi | A. Santoro | M. Antoniotti | A. Graudenzi | E. Derenzini | F. Ricci | M. Merli | C. Carlo-Stella | Davide Maspero | P. Corradini | A. Guidetti | A. Di Rocco | S. Bramanti | M. Magagnoli | L. Morello | M. Di Trani | Eleonora Calabretta | C. Monfrini